Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.

The Commonwealth Fund’s updated July 2025 brief on maternal mortality highlights how systemic disparities, Medicaid coverage ...

A New Zealand study finds patients are open to remote and general practitioner-led care when it is tailored to their needs.

Proper placement, device understanding, and ongoing support are key to helping children and adolescents with diabetes benefit from continuous glucose monitors (CGMs), explained Mary Vuong, PharmD, ...

With inflammation being the cause of dry eye in many cases, future treatment will likely target this aspect of dry eye.

Supplemental Nutrition Assistance Program (SNAP) benefits may slow cognitive decline in older adults, highlighting the ...

The decline in ovarian cancer mortality rates after 2003 can be attributed to advances in treatment, precision medicine, improved preventive strategies, and a reduced disease incidence, according to ...

In an extension trial, apremilast showed sustained clinical benefit and a consistent safety profile in children and ...

US ovarian cancer mortality declined from 1999 to 2020, but significant disparities remain among older women, non-Hispanic White women, and those living in rural areas, as well as in the Northeastern ...

Individuals with mental illness in America continue to face socioeconomic barriers when it comes to accessing necessary care ...

Following the FDA approval of linvoseltamab (Lynozyfic; Regeneron) for heavily pretreated multiple myeloma, Sundar Jagannath, MBBS, highlights its potential for earlier use, increased accessibility, ...

When updated food allergy prevention guidelines were directly provided to families, they led to earlier allergen introduction ...